Life ScienceCompany
US WorldMeds - CNS Portfolio Ownership
Who owns US WorldMeds - CNS Portfolio?
US WorldMeds - CNS Portfolio is owned by Supernus Pharmaceuticals. It was acquired on June 9, 2020.
US WorldMeds - CNS Portfolio Business Overview
Where is US WorldMeds - CNS Portfolio headquartered?
US WorldMeds - CNS Portfolio is headquartered in Kentucky.
What sector is US WorldMeds - CNS Portfolio in?
US WorldMeds - CNS Portfolio is a life science company.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.